Light Aircraft
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Lifestyle Drugs Market Research Report 2024
1 Lifestyle Drugs Market Overview
1.1 Product Overview and Scope of Lifestyle Drugs
1.2 Lifestyle Drugs Segment by Therapeutic Type
1.2.1 Global Lifestyle Drugs Sales Growth Rate Comparison by Therapeutic Type (2022-2028)
1.2.2 Depression
1.2.3 Dermatology
1.2.4 Sexual Dysfunction
1.2.5 Obesity
1.2.6 Others
1.3 Lifestyle Drugs Segment by Sales Channel
1.3.1 Global Lifestyle Drugs Sales Comparison by Sales Channel: (2022-2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Lifestyle Drugs Market Size Estimates and Forecasts
1.4.1 Global Lifestyle Drugs Revenue 2017-2028
1.4.2 Global Lifestyle Drugs Sales 2017-2028
1.4.3 Lifestyle Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Lifestyle Drugs Market Competition by Manufacturers
2.1 Global Lifestyle Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Lifestyle Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Lifestyle Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Lifestyle Drugs Manufacturing Sites, Area Served, Product Type
2.5 Lifestyle Drugs Market Competitive Situation and Trends
2.5.1 Lifestyle Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Lifestyle Drugs Players Market Share by Revenue
2.5.3 Global Lifestyle Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lifestyle Drugs Retrospective Market Scenario by Region
3.1 Global Lifestyle Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Lifestyle Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Lifestyle Drugs Market Facts & Figures by Country
3.3.1 North America Lifestyle Drugs Sales by Country
3.3.2 North America Lifestyle Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Lifestyle Drugs Market Facts & Figures by Country
3.4.1 Europe Lifestyle Drugs Sales by Country
3.4.2 Europe Lifestyle Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lifestyle Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Lifestyle Drugs Sales by Region
3.5.2 Asia Pacific Lifestyle Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Lifestyle Drugs Market Facts & Figures by Country
3.6.1 Latin America Lifestyle Drugs Sales by Country
3.6.2 Latin America Lifestyle Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Lifestyle Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Lifestyle Drugs Sales by Country
3.7.2 Middle East and Africa Lifestyle Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Lifestyle Drugs Historic Market Analysis by Type
4.1 Global Lifestyle Drugs Sales Market Share by Type (2017-2022)
4.2 Global Lifestyle Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Lifestyle Drugs Price by Type (2017-2022)
5 Global Lifestyle Drugs Historic Market Analysis by Sales Channel
5.1 Global Lifestyle Drugs Sales Market Share by Sales Channel (2017-2022)
5.2 Global Lifestyle Drugs Revenue Market Share by Sales Channel (2017-2022)
5.3 Global Lifestyle Drugs Price by Sales Channel (2017-2022)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Allergan Lifestyle Drugs Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lilly Lifestyle Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Lifestyle Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AstraZeneca Lifestyle Drugs Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Teva Lifestyle Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Sun Pharmacetuicals
6.6.1 Sun Pharmacetuicals Corporation Information
6.6.2 Sun Pharmacetuicals Description and Business Overview
6.6.3 Sun Pharmacetuicals Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Sun Pharmacetuicals Lifestyle Drugs Product Portfolio
6.6.5 Sun Pharmacetuicals Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Lifestyle Drugs Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Forendo Pharma
6.8.1 Forendo Pharma Corporation Information
6.8.2 Forendo Pharma Description and Business Overview
6.8.3 Forendo Pharma Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Forendo Pharma Lifestyle Drugs Product Portfolio
6.8.5 Forendo Pharma Recent Developments/Updates
6.9 Avolynt
6.9.1 Avolynt Corporation Information
6.9.2 Avolynt Description and Business Overview
6.9.3 Avolynt Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Avolynt Lifestyle Drugs Product Portfolio
6.9.5 Avolynt Recent Developments/Updates
6.10 Alkermes
6.10.1 Alkermes Corporation Information
6.10.2 Alkermes Description and Business Overview
6.10.3 Alkermes Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Alkermes Lifestyle Drugs Product Portfolio
6.10.5 Alkermes Recent Developments/Updates
6.11 Dong-A ST
6.11.1 Dong-A ST Corporation Information
6.11.2 Dong-A ST Lifestyle Drugs Description and Business Overview
6.11.3 Dong-A ST Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Dong-A ST Lifestyle Drugs Product Portfolio
6.11.5 Dong-A ST Recent Developments/Updates
6.12 Dermira
6.12.1 Dermira Corporation Information
6.12.2 Dermira Lifestyle Drugs Description and Business Overview
6.12.3 Dermira Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Dermira Lifestyle Drugs Product Portfolio
6.12.5 Dermira Recent Developments/Updates
6.13 Avanir Pharmaceuticals
6.13.1 Avanir Pharmaceuticals Corporation Information
6.13.2 Avanir Pharmaceuticals Lifestyle Drugs Description and Business Overview
6.13.3 Avanir Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Avanir Pharmaceuticals Lifestyle Drugs Product Portfolio
6.13.5 Avanir Pharmaceuticals Recent Developments/Updates
6.14 Menlo Therapeutics
6.14.1 Menlo Therapeutics Corporation Information
6.14.2 Menlo Therapeutics Lifestyle Drugs Description and Business Overview
6.14.3 Menlo Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Menlo Therapeutics Lifestyle Drugs Product Portfolio
6.14.5 Menlo Therapeutics Recent Developments/Updates
6.15 Galderma
6.15.1 Galderma Corporation Information
6.15.2 Galderma Lifestyle Drugs Description and Business Overview
6.15.3 Galderma Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Galderma Lifestyle Drugs Product Portfolio
6.15.5 Galderma Recent Developments/Updates
6.16 Cerecor
6.16.1 Cerecor Corporation Information
6.16.2 Cerecor Lifestyle Drugs Description and Business Overview
6.16.3 Cerecor Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Cerecor Lifestyle Drugs Product Portfolio
6.16.5 Cerecor Recent Developments/Updates
6.17 Corcept Therapeutics
6.17.1 Corcept Therapeutics Corporation Information
6.17.2 Corcept Therapeutics Lifestyle Drugs Description and Business Overview
6.17.3 Corcept Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Corcept Therapeutics Lifestyle Drugs Product Portfolio
6.17.5 Corcept Therapeutics Recent Developments/Updates
6.18 Anterios
6.18.1 Anterios Corporation Information
6.18.2 Anterios Lifestyle Drugs Description and Business Overview
6.18.3 Anterios Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Anterios Lifestyle Drugs Product Portfolio
6.18.5 Anterios Recent Developments/Updates
6.19 Euthymics Bioscience
6.19.1 Euthymics Bioscience Corporation Information
6.19.2 Euthymics Bioscience Lifestyle Drugs Description and Business Overview
6.19.3 Euthymics Bioscience Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Euthymics Bioscience Lifestyle Drugs Product Portfolio
6.19.5 Euthymics Bioscience Recent Developments/Updates
6.20 Cosmo Pharmaceuticals
6.20.1 Cosmo Pharmaceuticals Corporation Information
6.20.2 Cosmo Pharmaceuticals Lifestyle Drugs Description and Business Overview
6.20.3 Cosmo Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Cosmo Pharmaceuticals Lifestyle Drugs Product Portfolio
6.20.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.21 AndroScience
6.21.1 AndroScience Corporation Information
6.21.2 AndroScience Lifestyle Drugs Description and Business Overview
6.21.3 AndroScience Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.21.4 AndroScience Lifestyle Drugs Product Portfolio
6.21.5 AndroScience Recent Developments/Updates
6.22 Acerus Pharmaceuticals
6.22.1 Acerus Pharmaceuticals Corporation Information
6.22.2 Acerus Pharmaceuticals Lifestyle Drugs Description and Business Overview
6.22.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Acerus Pharmaceuticals Lifestyle Drugs Product Portfolio
6.22.5 Acerus Pharmaceuticals Recent Developments/Updates
6.23 Celtaxsys
6.23.1 Celtaxsys Corporation Information
6.23.2 Celtaxsys Lifestyle Drugs Description and Business Overview
6.23.3 Celtaxsys Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Celtaxsys Lifestyle Drugs Product Portfolio
6.23.5 Celtaxsys Recent Developments/Updates
6.24 Futura Medical Developments
6.24.1 Futura Medical Developments Corporation Information
6.24.2 Futura Medical Developments Lifestyle Drugs Description and Business Overview
6.24.3 Futura Medical Developments Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Futura Medical Developments Lifestyle Drugs Product Portfolio
6.24.5 Futura Medical Developments Recent Developments/Updates
6.25 Follicum
6.25.1 Follicum Corporation Information
6.25.2 Follicum Lifestyle Drugs Description and Business Overview
6.25.3 Follicum Lifestyle Drugs Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Follicum Lifestyle Drugs Product Portfolio
6.25.5 Follicum Recent Developments/Updates
7 Lifestyle Drugs Manufacturing Cost Analysis
7.1 Lifestyle Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lifestyle Drugs
7.4 Lifestyle Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lifestyle Drugs Distributors List
8.3 Lifestyle Drugs Customers
9 Lifestyle Drugs Market Dynamics
9.1 Lifestyle Drugs Industry Trends
9.2 Lifestyle Drugs Market Drivers
9.3 Lifestyle Drugs Market Challenges
9.4 Lifestyle Drugs Market Restraints
10 Global Market Forecast
10.1 Lifestyle Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Lifestyle Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Lifestyle Drugs by Type (2023-2028)
10.2 Lifestyle Drugs Market Estimates and Projections by Sales Channel
10.2.1 Global Forecasted Sales of Lifestyle Drugs by Sales Channel (2023-2028)
10.2.2 Global Forecasted Revenue of Lifestyle Drugs by Sales Channel (2023-2028)
10.3 Lifestyle Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lifestyle Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Lifestyle Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Lifestyle Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Lifestyle Drugs Sales Growth Rate Comparison by Sales Channel (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Lifestyle Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Lifestyle Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Lifestyle Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Lifestyle Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Lifestyle Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Lifestyle Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Lifestyle Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Lifestyle Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Lifestyle Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Lifestyle Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lifestyle Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Lifestyle Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Lifestyle Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Lifestyle Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Lifestyle Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Lifestyle Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Lifestyle Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Lifestyle Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Lifestyle Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Lifestyle Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Lifestyle Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Lifestyle Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Lifestyle Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Lifestyle Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Lifestyle Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Lifestyle Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Lifestyle Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Lifestyle Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Lifestyle Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Lifestyle Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Lifestyle Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Lifestyle Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Lifestyle Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Lifestyle Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Lifestyle Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Lifestyle Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Lifestyle Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Lifestyle Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Lifestyle Drugs Revenue Share by Type (2017-2022)
Table 43. Global Lifestyle Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Lifestyle Drugs Sales (K Units) by Sales Channel (2017-2022)
Table 45. Global Lifestyle Drugs Sales Market Share by Sales Channel (2017-2022)
Table 46. Global Lifestyle Drugs Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 47. Global Lifestyle Drugs Revenue Share by Sales Channel (2017-2022)
Table 48. Global Lifestyle Drugs Price by Sales Channel (2017-2022) & (USD/Unit)
Table 49. Allergan Corporation Information
Table 50. Allergan Description and Business Overview
Table 51. Allergan Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Allergan Lifestyle Drugs Product
Table 53. Allergan Recent Developments/Updates
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Description and Business Overview
Table 56. Eli Lilly Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Eli Lilly Lifestyle Drugs Product
Table 58. Eli Lilly Recent Developments/Updates
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Pfizer Lifestyle Drugs Product
Table 63. Pfizer Recent Developments/Updates
Table 64. AstraZeneca Corporation Information
Table 65. AstraZeneca Description and Business Overview
Table 66. AstraZeneca Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. AstraZeneca Lifestyle Drugs Product
Table 68. AstraZeneca Recent Developments/Updates
Table 69. Teva Corporation Information
Table 70. Teva Description and Business Overview
Table 71. Teva Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Teva Lifestyle Drugs Product
Table 73. Teva Recent Developments/Updates
Table 74. Sun Pharmacetuicals Corporation Information
Table 75. Sun Pharmacetuicals Description and Business Overview
Table 76. Sun Pharmacetuicals Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Sun Pharmacetuicals Lifestyle Drugs Product
Table 78. Sun Pharmacetuicals Recent Developments/Updates
Table 79. Merck Corporation Information
Table 80. Merck Description and Business Overview
Table 81. Merck Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Merck Lifestyle Drugs Product
Table 83. Merck Recent Developments/Updates
Table 84. Forendo Pharma Corporation Information
Table 85. Forendo Pharma Description and Business Overview
Table 86. Forendo Pharma Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Forendo Pharma Lifestyle Drugs Product
Table 88. Forendo Pharma Recent Developments/Updates
Table 89. Avolynt Corporation Information
Table 90. Avolynt Description and Business Overview
Table 91. Avolynt Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Avolynt Lifestyle Drugs Product
Table 93. Avolynt Recent Developments/Updates
Table 94. Alkermes Corporation Information
Table 95. Alkermes Description and Business Overview
Table 96. Alkermes Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Alkermes Lifestyle Drugs Product
Table 98. Alkermes Recent Developments/Updates
Table 99. Dong-A ST Corporation Information
Table 100. Dong-A ST Description and Business Overview
Table 101. Dong-A ST Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Dong-A ST Lifestyle Drugs Product
Table 103. Dong-A ST Recent Developments/Updates
Table 104. Dermira Corporation Information
Table 105. Dermira Description and Business Overview
Table 106. Dermira Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Dermira Lifestyle Drugs Product
Table 108. Dermira Recent Developments/Updates
Table 109. Avanir Pharmaceuticals Corporation Information
Table 110. Avanir Pharmaceuticals Description and Business Overview
Table 111. Avanir Pharmaceuticals Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Avanir Pharmaceuticals Lifestyle Drugs Product
Table 113. Avanir Pharmaceuticals Recent Developments/Updates
Table 114. Menlo Therapeutics Corporation Information
Table 115. Menlo Therapeutics Description and Business Overview
Table 116. Menlo Therapeutics Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Menlo Therapeutics Lifestyle Drugs Product
Table 118. Menlo Therapeutics Recent Developments/Updates
Table 119. Galderma Corporation Information
Table 120. Galderma Description and Business Overview
Table 121. Galderma Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Galderma Lifestyle Drugs Product
Table 123. Galderma Recent Developments/Updates
Table 124. Cerecor Corporation Information
Table 125. Cerecor Description and Business Overview
Table 126. Cerecor Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Cerecor Lifestyle Drugs Product
Table 128. Cerecor Recent Developments/Updates
Table 129. Corcept Therapeutics Corporation Information
Table 130. Corcept Therapeutics Description and Business Overview
Table 131. Corcept Therapeutics Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Corcept Therapeutics Lifestyle Drugs Product
Table 133. Corcept Therapeutics Recent Developments/Updates
Table 134. Anterios Corporation Information
Table 135. Anterios Description and Business Overview
Table 136. Anterios Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Anterios Lifestyle Drugs Product
Table 138. Anterios Recent Developments/Updates
Table 139. Euthymics Bioscience Corporation Information
Table 140. Euthymics Bioscience Description and Business Overview
Table 141. Euthymics Bioscience Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Euthymics Bioscience Lifestyle Drugs Product
Table 143. Euthymics Bioscience Recent Developments/Updates
Table 144. Cosmo Pharmaceuticals Corporation Information
Table 145. Cosmo Pharmaceuticals Description and Business Overview
Table 146. Cosmo Pharmaceuticals Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Cosmo Pharmaceuticals Lifestyle Drugs Product
Table 148. Cosmo Pharmaceuticals Recent Developments/Updates
Table 149. AndroScience Corporation Information
Table 150. AndroScience Description and Business Overview
Table 151. AndroScience Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. AndroScience Lifestyle Drugs Product
Table 153. AndroScience Recent Developments/Updates
Table 154. Acerus Pharmaceuticals Corporation Information
Table 155. Acerus Pharmaceuticals Description and Business Overview
Table 156. Acerus Pharmaceuticals Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Acerus Pharmaceuticals Lifestyle Drugs Product
Table 158. Acerus Pharmaceuticals Recent Developments/Updates
Table 159. Celtaxsys Corporation Information
Table 160. Celtaxsys Description and Business Overview
Table 161. Celtaxsys Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 162. Celtaxsys Lifestyle Drugs Product
Table 163. Celtaxsys Recent Developments/Updates
Table 164. Futura Medical Developments Corporation Information
Table 165. Futura Medical Developments Description and Business Overview
Table 166. Futura Medical Developments Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 167. Futura Medical Developments Lifestyle Drugs Product
Table 168. Futura Medical Developments Recent Developments/Updates
Table 169. Follicum Corporation Information
Table 170. Follicum Description and Business Overview
Table 171. Follicum Lifestyle Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 172. Follicum Lifestyle Drugs Product
Table 173. Follicum Recent Developments/Updates
Table 174. Production Base and Market Concentration Rate of Raw Material
Table 175. Key Suppliers of Raw Materials
Table 176. Lifestyle Drugs Distributors List
Table 177. Lifestyle Drugs Customers List
Table 178. Lifestyle Drugs Market Trends
Table 179. Lifestyle Drugs Market Drivers
Table 180. Lifestyle Drugs Market Challenges
Table 181. Lifestyle Drugs Market Restraints
Table 182. Global Lifestyle Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 183. Global Lifestyle Drugs Sales Market Share Forecast by Type (2023-2028)
Table 184. Global Lifestyle Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 185. Global Lifestyle Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 186. Global Lifestyle Drugs Sales Forecast by Sales Channel (2023-2028) & (K Units)
Table 187. Global Lifestyle Drugs Sales Market Share Forecast by Sales Channel (2023-2028)
Table 188. Global Lifestyle Drugs Revenue Forecast by Sales Channel (2023-2028) & (US$ Million)
Table 189. Global Lifestyle Drugs Revenue Market Share Forecast by Sales Channel (2023-2028)
Table 190. Global Lifestyle Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 191. Global Lifestyle Drugs Sales Market Share Forecast by Region (2023-2028)
Table 192. Global Lifestyle Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 193. Global Lifestyle Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lifestyle Drugs
Figure 2. Global Lifestyle Drugs Market Share by Type in 2021 & 2028
Figure 3. Depression Product Picture
Figure 4. Dermatology Product Picture
Figure 5. Sexual Dysfunction Product Picture
Figure 6. Obesity Product Picture
Figure 7. Others Product Picture
Figure 8. Global Lifestyle Drugs Market Share by Sales Channel in 2021 & 2028
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Lifestyle Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Lifestyle Drugs Market Size (2017-2028) & (US$ Million)
Figure 14. Global Lifestyle Drugs Sales (2017-2028) & (K Units)
Figure 15. Lifestyle Drugs Sales Share by Manufacturers in 2021
Figure 16. Global Lifestyle Drugs Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Lifestyle Drugs Players: Market Share by Revenue in 2021
Figure 18. Lifestyle Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Lifestyle Drugs Sales Market Share by Region (2017-2022)
Figure 20. Global Lifestyle Drugs Sales Market Share by Region in 2021
Figure 21. Global Lifestyle Drugs Revenue Market Share by Region (2017-2022)
Figure 22. Global Lifestyle Drugs Revenue Market Share by Region in 2021
Figure 23. U.S. Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. U.A.E Lifestyle Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Lifestyle Drugs by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Lifestyle Drugs
Figure 49. Manufacturing Process Analysis of Lifestyle Drugs
Figure 50. Lifestyle Drugs Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan Eli Lilly Pfizer AstraZeneca Teva Sun Pharmacetuicals Merck Forendo Pharma Avolynt Alkermes Dong-A ST Dermira Avanir Pharmaceuticals Menlo Therapeutics Galderma Cerecor Corcept Therapeutics Anterios Euthymics Bioscience Cosmo Pharmaceuticals AndroScience Acerus Pharmaceuticals Celtaxsys Futura Medical Developments Follicum